State of cancer care in Russia: Age and cancer. Features of localization structure, quality of recording, and survival of middle-aged patients with CNS tumors (a clinical-population study). Part 3

Cover Page

Cite item

Full Text

Abstract

According to the World Health Organization (WHO) standard, the middle age refers to the population between 45 and 59 years old. In the previous two studies, we examined the specific characteristics of the detailed localization structure of morbidity, mortality, and survival of children, adolescents, and young adults. This analysis of these characteristics for individuals belonging to the middle age group is conducted for the first time. The population belonging to this age group is most actively involved in public life, has a stable financial status, and often finds themselves at the peak of their professional and personal maturity. The concept of “middle age” encompasses three components. According to the WHO standards, the first component represents the total population aged 45 to 49 years. In the previous two studies, we examined the characteristics of the detailed localization structure of morbidity, mortality, and survival of children, adolescents, and young adults. The analysis of these characteristics for individuals belonging to the middle age group is conducted for the first time. The population that falls within this age group is most actively involved in public life, has a stable socioeconomic status, and often reaches the pinnacle of their professional and personal maturity. The concept of “middle age” encompasses three components. According to the standards of the World Health Organization (WHO), the first component represents the aggregate population aged 45 to 49 years.

About the authors

Vakhtang M. Merabishvili

N. N. Petrov National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation

Author for correspondence.
Email: MVM@niioncologii.ru
ORCID iD: 0000-0002-1521-455X
SPIN-code: 5705-6327

Dr.Med.Sci., Professor, Chief of the Oncological Statistics Scientific Laboratory

Russian Federation, Saint Petersburg

Anna O. Shakhzadova

Moscow Scientific Research Oncology Institute named after P. A. Herzen is a branch of the Federal State Budgetary Institution National Medical Research Center of Radiology under the Ministry of Health of Russia

Email: ann4761@yandex.ru

Senior Researcher at the Russian Center for Information Technology and Epidemiological Research in the Field of Oncology Chairman of the Scientific-Methodological Council on Development of Information Systems of Cancer Control of the Northwestern Federal District, Head of the Population-based Cancer Registry

Russian Federation, Moscow

Vladimir V. Perelygin

Saint Petersburg State Chemical and Pharmaceutical University of the Ministry of Health of the Russian Federation

Email: vladimir.pereligin@pharminnotech.com
ORCID iD: 0000-0002-0999-5644
SPIN-code: 3128-7451
Scopus Author ID: 13105602000
ResearcherId: AAV-6556-2020

Dr.Med.Sci., Professor, Head of the Industrial Ecology Department

Russian Federation, Saint Petersburg

References

  1. Merabishvili V. M. Coronaviruses and cancer in Russia / V. M. Merabishvili // Issues of Oncology. – 2022. – T. 68, No. 4. – P. 381-392. – doi: 10.37469/0507-3758-2022-68-4-381-392. (In Russ).
  2. Zlokachestvennye novoobrazovanija v Rossii v 2000 godu (zabolevaemost’ i smertnost’) / Pod red. V. I. Chissova, V. V. Starinskogo. – M.: MNIOI im. P. A. Gercena, 2002. – 264 s. (In Russ).
  3. Zlokachestvennye novoobrazovanija v Rossii v 2005 godu (zabolevaemost’ i smertnost’) / Pod red. V. I. Chissova, V. V. Starinskogo. – M.: MNIOI im. P. A. Gercena, 2007. – 252 s. (In Russ).
  4. Zlokachestvennye novoobrazovanija v Rossii v 2010 godu (zabolevaemost’ i smertnost’) / Pod red. V. I. Chissova, V. V. Starinskogo, G. V. Petrovoj. – M.: MNIOI im. P. A. Gercena, 2012. – 260 s. (In Russ).
  5. Zlokachestvennye novoobrazovanija v Rossii v 2015 godu (zabolevaemost’ i smertnost’) / Pod red. A. D. Kaprina, V. V. Starinskogo, G. V. Petrovoj. – M.: MNIOI im. P.A.Gercena – filial FGBU “NMIC radiologii” Minzdrava Rossii, 2017. – 250 s. (In Russ).
  6. Zlokachestvennye novoobrazovanija v Rossii v 2019 godu (zabolevaemost’ i smertnost’) / Pod red. A. D. Kaprina, V. V. Starinskogo, A. O. Shahzadovoj. – M.: MNIOI im. P. A. Gercena – filial FGBU “NMIC radiologii” Minzdrava Rossii, 2020. – 214 s. (In Russ).
  7. Zlokachestvennye novoobrazovanija v Rossii v 2020 godu (zabolevaemost’ i smertnost’) / Pod red. A. D. Kaprina, V. V. Starinskogo, A. O. Shahzadovoj. – M.: MNIOI im. P. A. Gercena – filial FGBU “NMIC radiologii” Minzdrava Rossii, 2021. – 252 s. (In Russ).
  8. Zlokachestvennye novoobrazovanija v Rossii v 2021 godu (zabolevaemost’ i smertnost’) / Pod red. A. D. Kaprina, V. V. Starinskogo, A. O. Shahzadovoj. – M.: MNIOI im. P. A. Gercena – filial FGBU “NMIC radiologii” Minzdrava Rossii, 2022. – 252 s. (In Russ).
  9. Merabishvili V. M. Analytical indicators. Accounting Reliability Index / V. M. Merabishvili // Questions of Oncology. – 2018. – T. 64, No. 3. – S. 445–452. (In Russ).
  10. Merabishvili V. M. The index of accounting reliability is the most important criterion for an objective assessment of the oncological service for all localizations of cancer, regardless of the level of mortality of patients / V. M. Merabishvili // Problems of oncology. – 2019. – T. 65, No. 4. – S. 510–515. (In Russ).
  11. Survival of cancer patients / V. M. Merabishvili, I. V. Kiselnikova, O. F. Chepik [et al.]. Volume Issue 2, Part I. – St. Petersburg: Publishing and printing company “COSTA”, 2011. – 332 p. – ISBN: 978-5-91258-176-2. (In Russ).
  12. Merabishvili V. M. Vyzhivaemost’ onkologicheskih bol’nyh. Vypusk vtoroj. Chast’ II / Pod red. Ju. A. Shherbuka. – SPb.: OOO “Izdatel’sko-poligraficheskaja kompanija “KOSTA”, 2011. – 408 s. (In Russ).
  13. Merabishvili V. M. Zlokachestvennye novoobrazovanija v Severo-Zapadnom federal’nom okruge Rossii (zabolevaemost’, smertnost’, dostovernost’ ucheta, vyzhivaemost’ bol’nyh). Jekspress-informacija. Vypusk pjatyj. / Pod red. prof. A. M. Beljaeva, prof. A. M. Shherbakova. SPb.: T8 Izdatel’skie tehnologii, 2020. (In Russ).
  14. Merabishvili V. M. Zlokachestvennye novoobrazovanija v Severo-Zapadnom federal’nom okruge Rossii (zabolevaemost’, smertnost’, dostovernost’ ucheta, vyzhivaemost’ bol’nyh). Jekspress-informacija. Vypusk shestoj. Posobie dlja vrachej / Pod red. chl.-korr. RAN, prof. A. M. Beljaeva. – SPb, (In Russ).
  15. Merabishvili V. M. The state of oncological care in Russia: one-year survival rate of patients with malignant neoplasms and mortality in the first year of life for all tumor locations. (population study at the level of the federal district) / V. M. Merabishvili, A. M. Belyaev // Issues of oncology. – – T. 69, No. 1. – P. 55-66. – doi: 10.37469/0507-3758-2023-69-1-55-66. (In Russ).
  16. Merabishvili V. M. The state of oncological care in Russia: the dynamics of five-year survival of patients with malignant neoplasms and its rank distribution across all tumor locations. Population study at the level of the North-Western Federal District / V. M. Merabishvili, A. M. Belyaev // Issues of Oncology. – – T. 69, No. 2. – P. 227-237. – doi: 10.37469/0507-3758-2023-69-2-227-237. (In Russ).
  17. Berrino F., Sant M., Verdecchia V., Capocaccia R., Hakulinen T., Estéve J., eds. Survival of cancer patients in Europe: the EUROCARE Study (IARC Scientific Publications No. 132). Lyon: International Agency for Research on Cancer, 1995.
  18. Berrino F., Capocaccia R., Coleman M.P., Esteve J., Gatta G., Hakulinen T., Micheli M., Sant M., Verdecchia V., eds. Survival of cancer patients in Europe: the EUROCARE-2 study (IARC Scientific Publications No. 151). Lyon: International Agency for Research on Cancer, 1999.
  19. Berrino F., Capocaccia R., Esteve J., Gatta G., Hakulinen T., Micheli M., Sant M., Verdecchia V., eds. EUROCARE-3: the survival of cancer patients diagnosed in Europe during 1990-94. Ann Oncol 2003; 14 (Suppl. 5): pp1-155
  20. Capocaccia R., Gavin A., Hakulinen T., Lutz J.M., Sant M. (eds.) Survival of cancer patients in Europe, 1995–2002. The EUROCARE-4 study. Eur J Cancer 2009; 45.
  21. De Angelis R., Sant M., Coleman M., Francisci S., Baili P., Pierannunzio D., Trama A., Visser O., Brenner H., Ardanaz E., Bielska-Lasota M., Engholm G., Nennecke A., Siesling S., Berrino F., Capocaccia R., and the EUROCARE-5 Working Group. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 – a population-based study. Lancet Oncol 2014; 15:23-34. DOI: 10.1016/ S1470-2045(13)70546-1

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. The structure of the main localization of malignant neoplasms among the male population of Russia in the age group of 45–49 years (2021) [8]

Download (92KB)
Indexing metadata
3. Fig. 2. The structure of the main localization of malignant neoplasms among the male population of Russia in the age group of 50–54 years (2021) [8]

Download (88KB)
Indexing metadata
4. Fig. 3. The main localization structure of malignant neoplasms among the male population of Russia in the age group 55–59 years (2021) [8]

Download (86KB)
Indexing metadata
5. Fig. 4. The main localization structure of malignant neoplasms among the female population of Russia age group 45–49 years (2021) [8]

Download (97KB)
Indexing metadata
6. Fig. 5. The structure of the main localization of malignant neoplasms among the female population of Russia in the age group of 50–54 years (2021) [8]

Download (92KB)
Indexing metadata
7. Fig. 6. The structure of the main localization of malignant neoplasms among the female population Russia age group 55–59 years (2021) [8]

Download (93KB)
Indexing metadata

Copyright (c) 2023 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies